Henry Schein (HSIC) Competitors

Cardinal Health (NYSE:CAH) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.

Do analysts recommend CAH or HSIC?

Cardinal Health currently has a consensus price target of $139.36, suggesting a potential upside of 8.06%. Henry Schein has a consensus price target of $81.10, suggesting a potential upside of 14.53%. Given Henry Schein's higher possible upside, analysts clearly believe Henry Schein is more favorable than Cardinal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardinal Health	0 Sell rating(s)	4 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.71
Henry Schein	0 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.64

Is CAH or HSIC more profitable?

Henry Schein has a net margin of 2.51% compared to Cardinal Health's net margin of 0.59%. Henry Schein's return on equity of 12.90% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardinal Health	0.59%	-59.57%	4.17%
Henry Schein	2.51%	12.90%	5.21%

Does the MarketBeat Community prefer CAH or HSIC?

Cardinal Health received 543 more outperform votes than Henry Schein when rated by MarketBeat users. Likewise, 71.42% of users gave Cardinal Health an outperform vote while only 51.63% of users gave Henry Schein an outperform vote.

Company	Underperform	Outperform
Cardinal Health	Outperform Votes 922 71.42%	Underperform Votes 369 28.58%
Henry Schein	Outperform Votes 379 51.63%	Underperform Votes 355 48.37%

Which has stronger valuation & earnings, CAH or HSIC?

Cardinal Health has higher revenue and earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardinal Health	$222.28B	0.14	$852M	$5.36	24.06
Henry Schein	$12.67B	0.70	$416M	$3.04	23.29

Which has more risk and volatility, CAH or HSIC?

Cardinal Health has a beta of 0.63, meaning that its share price is 37% less volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500.

Does the media refer more to CAH or HSIC?

In the previous week, Henry Schein had 46 more articles in the media than Cardinal Health. MarketBeat recorded 64 mentions for Henry Schein and 18 mentions for Cardinal Health. Cardinal Health's average media sentiment score of 1.39 beat Henry Schein's score of 0.25 indicating that Cardinal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cardinal Health	13 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Henry Schein	16 Very Positive mention(s)	7 Positive mention(s)	15 Neutral mention(s)	8 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do institutionals & insiders have more ownership in CAH or HSIC?

87.2% of Cardinal Health shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 0.1% of Cardinal Health shares are held by company insiders. Comparatively, 1.1% of Henry Schein shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Henry Schein beats Cardinal Health on 11 of the 19 factors compared between the two stocks.